{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:16:01Z","timestamp":1793272561415,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.anai.2023.08.012","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:22:54Z","timestamp":1692757374000},"page":"766-774.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The US Hereditary Angioedema Association Scientific Registry: hereditary angioedema demographics, disease severity, and comorbidities"],"prefix":"10.1016","volume":"131","author":[{"given":"Sandra C.","family":"Christiansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Wilmot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Zuraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.anai.2023.08.012_bib0001","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice. Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.anai.2023.08.012_bib0002","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.anai.2023.08.012_bib0003","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/21678707.2015.1063415","article-title":"The importance of natural histories for rare diseases","volume":"3","author":"Gavin","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"issue":"1","key":"10.1016\/j.anai.2023.08.012_bib0004","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13023-023-02719-0","article-title":"A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance","volume":"18","author":"Hageman","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.anai.2023.08.012_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/1479973119881777","article-title":"The importance of effective registries in pulmonary diseases and how to optimize their output","volume":"16","author":"Chorostowska-Wynimko","year":"2019","journal-title":"Chron Respir Dis"},{"issue":"10","key":"10.1016\/j.anai.2023.08.012_bib0006","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/pds.4962","article-title":"Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions","volume":"29","author":"Wu","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.anai.2023.08.012_bib0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40290-020-00332-1","article-title":"Establishing patient registries for rare diseases: rationale and challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharm Med"},{"issue":"1","key":"10.1016\/j.anai.2023.08.012_bib0008","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13023-018-0936-x","article-title":"From scientific discovery to treatments for rare diseases - the view from the National Center for Advancing Translational Sciences - Office of Rare Diseases Research","volume":"13","author":"Kaufmann","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.anai.2023.08.012_bib0009","doi-asserted-by":"crossref","unstructured":"Gliklich RE, Leavy MB, Dreyer NA, (eds.). Chapter 1, Patient Registries, Registries for Evaluating Patient Outcomes: A User\u2019s Guide. 4th edition. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562581\/. Accessed September 28, 2023.","DOI":"10.23970\/AHRQEPCREGISTRIES4"},{"key":"10.1016\/j.anai.2023.08.012_bib0010","unstructured":"EURORDIS-NORD-CORD Release a Joint Declaration of 10 Key Principles for Rare Disease Patient Registries, 2012. Available at: https:\/\/download2.eurordis.org\/documents\/pdf\/EURORDIS_NORD_CORD_JointDec_Registries_FINAL.pdf. Accessed September 28, 2023."},{"issue":"9","key":"10.1016\/j.anai.2023.08.012_bib0011","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/cea.14206","article-title":"The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema","volume":"52","author":"Maurer","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"Suppl 24","key":"10.1016\/j.anai.2023.08.012_bib0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/pai.13170","article-title":"Pediatric angioedema: essential features and preliminary results from the Hereditary Angioedema Global Registry in Italy","volume":"31","author":"Cancian","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.08.012_bib0013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2500\/aap.2015.36.3831","article-title":"Before and after, the impact of available on-demand treatment for HAE","volume":"36","author":"Christiansen","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.anai.2023.08.012_bib0014","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2500\/aap.2018.39.4123","article-title":"Hereditary angioedema from the patient's perspective: a follow-up patient survey","volume":"39","author":"Banerji","year":"2018","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.anai.2023.08.012_bib0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2500\/aap.2021.42.200127","article-title":"Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema","volume":"42","author":"Castaldo","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2023.08.012_bib0016","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl 1","key":"10.1016\/j.anai.2023.08.012_bib0017","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","article-title":"Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel","volume":"33","author":"Zuraw","year":"2012","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.anai.2023.08.012_bib0018","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-84-5-580","article-title":"Hereditary angioedema: the clinical syndrome and its management","volume":"84","author":"Frank","year":"1976","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.anai.2023.08.012_bib0019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","article-title":"Hereditary angioedema: new findings concerning symptoms, affected organs, and course","volume":"119","author":"Bork","year":"2006","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.anai.2023.08.012_bib0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.08.012_bib0021","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0009922815616886","article-title":"Pediatric hereditary angioedema: onset, diagnostic delay, and disease severity","volume":"55","author":"Christiansen","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"issue":"5","key":"10.1016\/j.anai.2023.08.012_bib0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"624","key":"10.1016\/j.anai.2023.08.012_bib0023","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/pgmj.53.624.627","article-title":"Hereditary angio-oedema with mesangiocapillary glomerulonephritis","volume":"53","author":"Plaza","year":"1977","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.anai.2023.08.012_bib0024","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0091-6749(86)90424-0","article-title":"Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease","volume":"77","author":"Brickman","year":"1986","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.08.012_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2169\/internalmedicine.31.94","article-title":"Hereditary angioedema complicated with chronic renal failure: report of sibling cases","volume":"31","author":"Nomura","year":"1992","journal-title":"Int Med"},{"issue":"808","key":"10.1016\/j.anai.2023.08.012_bib0026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/pgmj.69.808.95","article-title":"IgA nephropathy in hereditary angioedema","volume":"69","author":"Srinivasan","year":"1993","journal-title":"Postgrad Med J"},{"issue":"7","key":"10.1016\/j.anai.2023.08.012_bib0027","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/ndt\/13.7.1822","article-title":"Fibrillary glomerulonephritis occurring in association with hereditary angioneurotic oedema, pernicious anaemia and hypothyroidism","volume":"13","author":"Whitaker","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.anai.2023.08.012_bib0028","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.intimp.2011.11.013","article-title":"There is an increased risk of atherosclerosis in hereditary angioedema","volume":"12","author":"Demirturk","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.anai.2023.08.012_bib0029","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2004.12.1130","article-title":"Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema","volume":"115","author":"Szeplaki","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2023.08.012_bib0030","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.clinthera.2008.12.021","article-title":"Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema","volume":"30","author":"Birjmohun","year":"2008","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.anai.2023.08.012_bib0031","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2007.09.025","article-title":"Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients","volume":"198","author":"Szegedi","year":"2008","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.anai.2023.08.012_bib0032","doi-asserted-by":"crossref","first-page":"e12135","DOI":"10.1002\/clt2.12135","article-title":"Comorbidities in hereditary angioedema\u2014a population-based cohort study","volume":"12","author":"Sundler Bj\u00f6rkman","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.08.012_bib0033","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cardiores.2006.10.014","article-title":"Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation","volume":"73","author":"Li","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.anai.2023.08.012_bib0034","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.peptides.2007.05.010","article-title":"Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling","volume":"28","author":"Yin","year":"2007","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.anai.2023.08.012_bib0035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/hr.2010.82","article-title":"Cardioprotective properties of bradykinin: role of the B(2) receptor","volume":"33","author":"Manolis","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.anai.2023.08.012_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174493","article-title":"Dexmedetomidine protects the heart against ischemia reperfusion injury via regulation of the bradykinin receptors","volume":"911","author":"Song","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.anai.2023.08.012_bib0037","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/acschemneuro.1c00054","article-title":"Bradykinin activates the bradykinin B2 receptor to ameliorate neuronal injury in a rat model of spinal cord ischemia-reperfusion injury","volume":"12","author":"Yang","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.anai.2023.08.012_bib0038","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaip.2019.10.004","article-title":"International consensus on the use of genetics in the management of hereditary angioedema","volume":"8","author":"Germenis","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.08.012_bib0039","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jaip.2021.03.008","article-title":"The expanding spectrum of mutations in hereditary angioedema","volume":"9","author":"Veronez","year":"2021","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623005896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623005896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:32:44Z","timestamp":1761053564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623005896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1081120623005896"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.08.012","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The US Hereditary Angioedema Association Scientific Registry: hereditary angioedema demographics, disease severity, and comorbidities","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American College of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}